Treatment options such as corticosteroids, immunoglobulins medicines, blood or platelet transfusions, or splenectomy are used for thrombocytopenia patients
Parkinson’s disease (PD), a progressive disorder of the central nervous system, affects every 1 in 100 persons, aged around 70 in Europe
Single photon emission tomography imaging in Patients with Lyme Disease Treated with Human Embryonic Stem Cells
The purpose of this study was to evaluate the longitudinal changes in brain perfusion in patients with Lyme disease treated with human embryonic stem cells.
“Reporting Innovations and Adaptations Employed for Statistical Evaluation of Efficacy of Human Embryonic Stem Cell Therapy in Spinal Cord Injury Cases”
The patients admitted to NUTECH Mediworld create a random and unbiased database. Forty-six symptoms assess spinal cord injury (SCI) cases.
A Functional Scoring System to Assess the Level of Impairment in Patients with Low Vision Impairment
Background: Low vision is referred to as visual impairment (VI) if it is not cured through surgery, drugs, spectacles or contact lenses.
To develop a new scoring system, nutech functional scores (NFS) for assessing the patients with spinal cord injury (SCI).
Comparison of Nutech Functional Score with European Stroke Scale for Patients with Cerebrovascular Accident Treated with Human Embryonic Stem Cells: NFS for CVA Patients Treated with hESCs
Purpose—Stem cell therapy is a promising modality for treatment of patients with chronic cerebrovascular accident (CVA) in whom treatment
A Review of the Emerging Potential Therapy for Neurological Disorders: Human Embryonic Stem Cell Therapy
The first human embryonic stem cell (hESC) line was developed in the late nineties.
Background: Autism spectrum disorder is a neurodevelopmental disorder accompanied by weak immune system and neuroinflammation.
Magnetic Resonance Imaging Tractography as a Diagnostic Tool in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cells
Spinal cord injury is a cause of severe disability and mortality. The pharmacological and non-pharmacological methods used, are unable to improve the quality of life in spinal cord injury.